back to US directory
us clinical guidance

Transient loss of consciousness and syncope

US initial assessment, risk stratification and targeted testing for syncope and other transient loss of consciousness.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team 路 Clinical editorial review 路 reviewed 2026-08-20 路 due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults and children with a transient loss of consciousness suspected to be syncope. The source also discusses pediatric presentations, but seizure, intoxication, metabolic loss of consciousness, head trauma and persistent altered mental status require their own pathways. The first task is to establish whether true transient loss of consciousness occurred and whether a serious condition is present.
sources for this section:ACC/AHA/HRS syncope

The Bottom Line

  • Perform a detailed history, physical examination and resting 12-lead ECG in the initial syncope evaluation.
  • Hospital evaluation and treatment are recommended when syncope is associated with a serious medical condition identified during the initial assessment.
  • Do not order routine comprehensive laboratory panels, neurologic imaging or EEG when the history and examination do not support them; testing should answer a specific diagnostic question.
  • Vasovagal syncope is common and benefits from a clear explanation of diagnosis and prognosis, but that conclusion follows appropriate risk assessment.
  • Choose ambulatory rhythm monitoring, echocardiography, exercise testing, autonomic assessment or electrophysiology selectively from suspected mechanism and event frequency.
sources for this section:ACC/AHA/HRS syncope

Practical clinical workflow

1
Confirm loss of consciousness, duration, posture, prodrome, triggers, movements, color, injury and recovery using a witness account whenever possible.
2
Review cardiac and neurologic history, family sudden death, medicines and substances; obtain orthostatic vital signs, cardiovascular and neurologic examinations, and a 12-lead ECG.
3
Identify serious cardiac, bleeding, pulmonary embolic, pregnancy-related, metabolic or neurologic conditions and decide on hospital versus outpatient evaluation.
4
If no emergency feature is present, formulate the most likely mechanism and select only tests that can confirm it or change risk.
5
Provide driving, work, sports, hydration, trigger and return precautions appropriate to the suspected cause and applicable state rules.
sources for this section:ACC/AHA/HRS syncope

Safety boundaries and escalation

  • Syncope during exertion or while supine, with chest pain, palpitations, dyspnea, major bleeding, persistent abnormal vital signs or a markedly abnormal ECG needs urgent cardiac evaluation.
  • Family history of sudden death, known structural heart disease, severe anemia, pregnancy complication or recurrent injury raises the escalation threshold.
  • Focal neurologic deficit, prolonged confusion or persistent unconsciousness is not routine uncomplicated syncope and requires an alternate emergency pathway.
  • Do not reassure or clear driving and competitive sport until the likely cause and recurrence risk have been assessed under relevant state and professional rules.
sources for this section:ACC/AHA/HRS syncope

Localization

Use the ACC/AHA/HRS risk framework and applicable US state driving, reporting and athletic-participation rules. Local access to observation, telemetry and ambulatory monitoring shapes disposition but should not dilute serious-risk assessment.
sources for this section:ACC/AHA/HRS syncope

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American College of Cardiology, American Heart Association, and Heart Rhythm Society2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With SyncopeDOI 10.1161/CIR.0000000000000499 路 published 2017-03-09 路 accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page鈥檚 provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what鈥攊f anything鈥攜ou may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.